Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Zigler

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Research|October 17, 2008
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humansFernanda I Staquicini, Anita Tandle, Steven K Libutti, et al.
Melanoma Research|July 9, 2011
A phase II study of gefitinib in patients with metastatic melanomaSapna P Patel, Kevin B Kim, Nicholas E Papadopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Nature Communications|January 31, 2013
Src activation by β-adrenoreceptors is a key switch for tumour metastasisGuillermo N Armaiz-Pena, Julie K Allen, Anthony Cruz, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Research|October 17, 2008
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humansFernanda I Staquicini, Anita Tandle, Steven K Libutti, et al.
Melanoma Research|July 9, 2011
A phase II study of gefitinib in patients with metastatic melanomaSapna P Patel, Kevin B Kim, Nicholas E Papadopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2025
Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumorsDerrick Broka, Shoshana Klein, Alexei Shir, et al.
Nature Communications|January 31, 2013
Src activation by β-adrenoreceptors is a key switch for tumour metastasisGuillermo N Armaiz-Pena, Julie K Allen, Anthony Cruz, et al.
Pageof 3